ID   TPST2_HUMAN             Reviewed;         377 AA.
AC   O60704; B3KQA7; Q6FI98; Q9H0V4;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Protein-tyrosine sulfotransferase 2;
DE            EC=2.8.2.20;
DE   AltName: Full=Tyrosylprotein sulfotransferase 2;
DE            Short=TPST-2;
GN   Name=TPST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9736702; DOI=10.1073/pnas.95.19.11134;
RA   Beisswanger R., Corbeil D., Vannier C., Thiele C., Dohrmann U.,
RA   Kellner R., Ashman K., Niehrs C., Huttner W.B.;
RT   "Existence of distinct tyrosylprotein sulfotransferase genes:
RT   molecular characterization of tyrosylprotein sulfotransferase-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11134-11139(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9733778; DOI=10.1074/jbc.273.38.24770;
RA   Ouyang Y.-B., Moore K.L.;
RT   "Molecular cloning and expression of human and mouse tyrosylprotein
RT   sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in
RT   Caenorhabditis elegans.";
RL   J. Biol. Chem. 273:24770-24774(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bennett E.P.;
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 43-359 IN COMPLEX WITH
RP   SUBSTRATE PEPTIDE, DISULFIDE BONDS, SUBUNIT, ACTIVE SITE, AND
RP   MUTAGENESIS OF ARG-78; GLU-99; ARG-101; TRP-113; LYS-158; THR-198 AND
RP   SER-285.
RX   PubMed=23481380; DOI=10.1038/ncomms2593;
RA   Teramoto T., Fujikawa Y., Kawaguchi Y., Kurogi K., Soejima M.,
RA   Adachi R., Nakanishi Y., Mishiro-Sato E., Liu M.C., Sakakibara Y.,
RA   Suiko M., Kimura M., Kakuta Y.;
RT   "Crystal structure of human tyrosylprotein sulfotransferase-2 reveals
RT   the mechanism of protein tyrosine sulfation reaction.";
RL   Nat. Commun. 4:1572-1572(2013).
CC   -!- FUNCTION: Catalyzes the O-sulfation of tyrosine residues within
CC       acidic motifs of polypeptides.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + protein tyrosine
CC       = adenosine 3',5'-bisphosphate + protein tyrosine-O-sulfate.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:23481380}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:9736702}.
CC   -!- MISCELLANEOUS: Substrate peptides must be flexible in order to
CC       adopt an L-shaped conformation in the deep binding cleft.
CC   -!- SIMILARITY: Belongs to the protein sulfotransferase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF061254; AAC34296.1; -; mRNA.
DR   EMBL; AF049891; AAC36061.1; -; mRNA.
DR   EMBL; AJ006198; CAA06906.1; -; mRNA.
DR   EMBL; AL136623; CAB66558.1; -; mRNA.
DR   EMBL; CR456597; CAG30483.1; -; mRNA.
DR   EMBL; CR533528; CAG38559.1; -; mRNA.
DR   EMBL; AK074538; BAG51969.1; -; mRNA.
DR   EMBL; AK075139; BAG52071.1; -; mRNA.
DR   EMBL; Z95115; CAB62950.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59726.1; -; Genomic_DNA.
DR   EMBL; BC001057; AAH01057.1; -; mRNA.
DR   EMBL; BC017509; AAH17509.1; -; mRNA.
DR   CCDS; CCDS13839.1; -.
DR   RefSeq; NP_001008566.1; NM_001008566.1.
DR   RefSeq; NP_003586.3; NM_003595.3.
DR   UniGene; Hs.632768; -.
DR   PDB; 3AP1; X-ray; 1.90 A; A/B=43-359.
DR   PDB; 3AP2; X-ray; 2.40 A; A/B=43-359.
DR   PDB; 3AP3; X-ray; 3.50 A; A/B/C/D=43-377.
DR   PDBsum; 3AP1; -.
DR   PDBsum; 3AP2; -.
DR   PDBsum; 3AP3; -.
DR   ProteinModelPortal; O60704; -.
DR   SMR; O60704; -.
DR   BioGrid; 114037; 10.
DR   MINT; MINT-4721342; -.
DR   STRING; 9606.ENSP00000339813; -.
DR   BindingDB; O60704; -.
DR   ChEMBL; CHEMBL3178; -.
DR   iPTMnet; O60704; -.
DR   PhosphoSitePlus; O60704; -.
DR   BioMuta; TPST2; -.
DR   EPD; O60704; -.
DR   MaxQB; O60704; -.
DR   PaxDb; O60704; -.
DR   PeptideAtlas; O60704; -.
DR   PRIDE; O60704; -.
DR   DNASU; 8459; -.
DR   Ensembl; ENST00000338754; ENSP00000339813; ENSG00000128294.
DR   Ensembl; ENST00000398110; ENSP00000381180; ENSG00000128294.
DR   Ensembl; ENST00000403880; ENSP00000385192; ENSG00000128294.
DR   GeneID; 8459; -.
DR   KEGG; hsa:8459; -.
DR   UCSC; uc003acw.4; human.
DR   CTD; 8459; -.
DR   DisGeNET; 8459; -.
DR   GeneCards; TPST2; -.
DR   HGNC; HGNC:12021; TPST2.
DR   HPA; HPA021054; -.
DR   MIM; 603126; gene.
DR   neXtProt; NX_O60704; -.
DR   OpenTargets; ENSG00000128294; -.
DR   PharmGKB; PA36700; -.
DR   eggNOG; KOG3988; Eukaryota.
DR   eggNOG; ENOG410XQ2X; LUCA.
DR   GeneTree; ENSGT00390000006030; -.
DR   HOGENOM; HOG000253020; -.
DR   HOVERGEN; HBG001270; -.
DR   InParanoid; O60704; -.
DR   KO; K01021; -.
DR   OMA; GKDKCLP; -.
DR   OrthoDB; EOG091G09YJ; -.
DR   PhylomeDB; O60704; -.
DR   TreeFam; TF312910; -.
DR   BRENDA; 2.8.2.20; 2681.
DR   ChiTaRS; TPST2; human.
DR   EvolutionaryTrace; O60704; -.
DR   GenomeRNAi; 8459; -.
DR   PRO; PR:O60704; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000128294; -.
DR   CleanEx; HS_TPST2; -.
DR   ExpressionAtlas; O60704; baseline and differential.
DR   Genevisible; O60704; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:LIFEdb.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0008476; F:protein-tyrosine sulfotransferase activity; IBA:GO_Central.
DR   GO; GO:0006478; P:peptidyl-tyrosine sulfation; IBA:GO_Central.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR026634; TPST.
DR   PANTHER; PTHR12788; PTHR12788; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; Membrane; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    377       Protein-tyrosine sulfotransferase 2.
FT                                /FTId=PRO_0000189829.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     25       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     26    377       Lumenal. {ECO:0000255}.
FT   ACT_SITE     78     78       {ECO:0000269|PubMed:23481380}.
FT   ACT_SITE     99     99       {ECO:0000269|PubMed:23481380}.
FT   SITE        158    158       Transition state stabilizer.
FT   SITE        285    285       Transition state stabilizer.
FT   CARBOHYD    343    343       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    368    368       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     96    156       {ECO:0000269|PubMed:23481380}.
FT   DISULFID    225    233       {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN      78     78       R->A: Significantly reduced enzymatic
FT                                activity. {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN      99     99       E->A: Abolishes sulfotransferase
FT                                activity. {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN     101    101       R->A: Prevents dimerization.
FT                                {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN     113    113       W->A: Prevents dimerization.
FT                                {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN     158    158       K->A: Significantly reduced enzymatic
FT                                activity. {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN     198    198       T->A: Decreases activity sulfotransferase
FT                                activity. {ECO:0000269|PubMed:23481380}.
FT   MUTAGEN     285    285       S->A: Abolishes sulfotransferase
FT                                activity. {ECO:0000269|PubMed:23481380}.
FT   CONFLICT     26     26       Q -> L (in Ref. 4; CAB66558 and 6;
FT                                CAG38559). {ECO:0000305}.
FT   CONFLICT     73     73       V -> E (in Ref. 4; CAB66558 and 6;
FT                                CAG38559). {ECO:0000305}.
FT   CONFLICT    115    115       K -> M (in Ref. 6; CAG38559).
FT                                {ECO:0000305}.
FT   STRAND       52     54       {ECO:0000244|PDB:3AP2}.
FT   STRAND       62     64       {ECO:0000244|PDB:3AP2}.
FT   STRAND       71     74       {ECO:0000244|PDB:3AP1}.
FT   STRAND       76     80       {ECO:0000244|PDB:3AP1}.
FT   HELIX        81     89       {ECO:0000244|PDB:3AP1}.
FT   HELIX       102    115       {ECO:0000244|PDB:3AP1}.
FT   HELIX       117    125       {ECO:0000244|PDB:3AP1}.
FT   HELIX       130    147       {ECO:0000244|PDB:3AP1}.
FT   STRAND      153    158       {ECO:0000244|PDB:3AP1}.
FT   HELIX       160    165       {ECO:0000244|PDB:3AP1}.
FT   HELIX       166    172       {ECO:0000244|PDB:3AP1}.
FT   STRAND      177    182       {ECO:0000244|PDB:3AP1}.
FT   HELIX       185    195       {ECO:0000244|PDB:3AP1}.
FT   HELIX       207    228       {ECO:0000244|PDB:3AP1}.
FT   TURN        230    232       {ECO:0000244|PDB:3AP1}.
FT   STRAND      233    237       {ECO:0000244|PDB:3AP1}.
FT   HELIX       238    243       {ECO:0000244|PDB:3AP1}.
FT   HELIX       245    256       {ECO:0000244|PDB:3AP1}.
FT   HELIX       262    265       {ECO:0000244|PDB:3AP1}.
FT   HELIX       267    269       {ECO:0000244|PDB:3AP1}.
FT   STRAND      283    285       {ECO:0000244|PDB:3AP3}.
FT   HELIX       286    289       {ECO:0000244|PDB:3AP1}.
FT   TURN        300    303       {ECO:0000244|PDB:3AP1}.
FT   HELIX       307    316       {ECO:0000244|PDB:3AP1}.
FT   HELIX       319    322       {ECO:0000244|PDB:3AP1}.
FT   STRAND      329    331       {ECO:0000244|PDB:3AP1}.
FT   HELIX       339    349       {ECO:0000244|PDB:3AP1}.
SQ   SEQUENCE   377 AA;  41912 MW;  A658E50151FDBC12 CRC64;
     MRLSVRRVLL AAGCALVLVL AVQLGQQVLE CRAVLAGLRS PRGAMRPEQE ELVMVGTNHV
     EYRYGKAMPL IFVGGVPRSG TTLMRAMLDA HPEVRCGEET RIIPRVLAMR QAWSKSGREK
     LRLDEAGVTD EVLDAAMQAF ILEVIAKHGE PARVLCNKDP FTLKSSVYLS RLFPNSKFLL
     MVRDGRASVH SMITRKVTIA GFDLSSYRDC LTKWNKAIEV MYAQCMEVGK EKCLPVYYEQ
     LVLHPRRSLK LILDFLGIAW SDAVLHHEDL IGKPGGVSLS KIERSTDQVI KPVNLEALSK
     WTGHIPGDVV RDMAQIAPML AQLGYDPYAN PPNYGNPDPF VINNTQRVLK GDYKTPANLK
     GYFQVNQNST SSHLGSS
//
